4.7 Review

Streamlining Ethical Review

Journal

ANNALS OF INTERNAL MEDICINE
Volume 153, Issue 10, Pages 655-657

Publisher

AMER COLL PHYSICIANS
DOI: 10.7326/0003-4819-153-10-201011160-00008

Keywords

-

Funding

  1. Intramural NIH HHS [Z99 CL999999] Funding Source: Medline

Ask authors/readers for more resources

The review system for human subjects research in the United States has been widely criticized in recent years for requirements that delay research without improving human subject protections. Any major reformulation of regulations may take some time to implement. However, current regulations often allow for streamlined ethics review that does not jeopardize-and may improve-protections for research participants. The authors discuss under-utilized options, including research that need not be classified as human subjects research, categories of studies that can be exempt from ethical review, studies that need only undergo expedited review by 1 institutional review board (IRB) member, and simplifying reviews of multicenter research by using the IRB of 1 institution. The authors speculate on multiple reasons for the underuse of these mechanisms and exhort IRBs and researchers to take advantage of these important opportunities to improve the review process.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available